BRANGANI, Corinna
 Distribuzione geografica
Continente #
EU - Europa 1.160
NA - Nord America 674
AS - Asia 244
AF - Africa 6
SA - Sud America 3
OC - Oceania 1
Totale 2.088
Nazione #
GB - Regno Unito 737
US - Stati Uniti d'America 665
CN - Cina 182
IT - Italia 154
SE - Svezia 64
IE - Irlanda 56
FI - Finlandia 40
FR - Francia 37
DE - Germania 35
KR - Corea 19
VN - Vietnam 12
SG - Singapore 11
JP - Giappone 9
GR - Grecia 8
CA - Canada 7
RU - Federazione Russa 7
UA - Ucraina 7
BE - Belgio 5
GH - Ghana 5
BR - Brasile 3
NL - Olanda 3
TR - Turchia 3
AL - Albania 2
IN - India 2
IR - Iran 2
MX - Messico 2
TH - Thailandia 2
BD - Bangladesh 1
CZ - Repubblica Ceca 1
HK - Hong Kong 1
LU - Lussemburgo 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RO - Romania 1
ZA - Sudafrica 1
Totale 2.088
Città #
Southend 711
Chandler 129
Beijing 64
Ashburn 62
Houston 62
Dublin 56
Ann Arbor 54
Woodbridge 49
Verona 39
Jacksonville 35
New York 29
Wilmington 29
Jinan 20
Helsinki 17
Lawrence 17
Princeton 17
Nanjing 15
Dearborn 13
Seoul 12
Lancaster 11
Hebei 10
Cagliari 9
Milan 9
Redmond 9
Tokyo 9
Boardman 8
Nikaia 8
Ningbo 8
Singapore 8
Dong Ket 7
Nanchang 7
Hangzhou 6
Shenyang 6
Accra 5
Brussels 5
Changsha 5
Palermo 5
Taizhou 5
Treviso 5
Washington 5
Zhengzhou 5
Falls Church 4
Seattle 4
Sindelfingen 4
Toronto 4
Yongin-si 4
Auburn Hills 3
Bologna 3
Catania 3
Fuzhou 3
Kitchener 3
Lido di Spina 3
Los Angeles 3
Napoli 3
San Paolo 3
Taiyuan 3
Alcamo 2
Catanzaro 2
Chengdu 2
Chicago 2
Clifton 2
Columbus 2
Coventry 2
Haikou 2
Lübeck 2
Redwood City 2
Tehran 2
Tirana 2
Trento 2
Vigevano 2
Apodaca 1
Arzignano 1
Auckland 1
Avola 1
Baltimore 1
Bengaluru 1
Cambridge 1
Cardano 1
Clearwater 1
Cleveland 1
Cosenza 1
Crotone 1
Desio 1
Dhaka 1
Dongguan 1
Downers Grove 1
Düsseldorf 1
Fairfield 1
Floridia 1
Geumjeong-gu 1
Groningen 1
Guangzhou 1
Ho Chi Minh City 1
Hong Kong 1
Icheon-si 1
Irving 1
Jesi 1
Johannesburg 1
Katowice 1
Kent 1
Totale 1.693
Nome #
American Diabetes Association 75th Scientific Meeting - Epidemiology/Genetics Section; Poster 1563-P: Pancreatic Beta-Cell Function, Insulin Sensitivity, and Metabolic Phenotypes in Type 2 Diabetes at the Time of Diagnosis—The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 615
Quantificazione del ruolo svolto dai principali fattori determinanti la glicemia durante un pasto misto, nei pazienti affetti da diabete mellito tipo 1 in terapia con microinfusore insulinico associato a glucosensore 136
Metabolic Effects of Exercise 131
"Presence and titer of GAD antibodies are determinants of beta cell function in patients with newly diagnosed type 2 diabetes mellitus: further insights in the metabolic phenotype of LADA patients" 124
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial. 118
Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes. 103
Glycated haemoglobin is inversely related to serum vitamin d levels in type 2 diabetic patients. 101
Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: The Verona Diabetic Foot Screening Program. 93
Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 93
A Novel Insulin/Glucose Model after a Mixed-Meal Test in Patients with Type 1 Diabetes on Insulin Pump Therapy 92
Relationship of Chronic Vascular Complications with Beta-Cell Dysfunction and Insulin Resistance in Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 90
A parsimonious model of a mixed-meal test in patients with type 1 diabetes in insulin pump therapy 86
Gli iperandrogenismi nella donna in post-menopausa 84
Interleukin-6 as a potential positive modulator of human beta-cell function: an exploratory analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6 79
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 77
Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9 61
Glomerular filtration rate decline in T2DM following diagnosis. The Verona newly diagnosed diabetes study-12 40
Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion 24
Totale 2.147
Categoria #
all - tutte 5.610
article - articoli 3.272
book - libri 0
conference - conferenze 1.691
curatela - curatele 0
other - altro 305
patent - brevetti 0
selected - selezionate 0
volume - volumi 342
Totale 11.220


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020349 32 21 20 24 35 35 27 18 16 53 32 36
2020/2021291 26 34 23 32 32 27 14 18 20 17 24 24
2021/2022218 29 54 15 16 16 17 7 14 8 4 14 24
2022/2023349 29 55 21 52 31 87 3 21 31 4 7 8
2023/2024286 10 22 17 24 23 67 7 19 4 35 46 12
2024/202516 16 0 0 0 0 0 0 0 0 0 0 0
Totale 2.147